ArticleMethods in molecular biology (Clifton, N.J.)2026
Supra-Nanoparticle Assemblies of Quantum Dots for Extracellular Immunolabeling.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With their exceptional fluorescence properties, colloidal semiconductor quantum dots (QDs) are powerful tools for bioanalysis and imaging. Examples of these properties include broad absorption spectra, narrow emission spectra, and both superior resistance to photobleaching and higher brightness than fluorescent dyes and proteins. Nevertheless, demanding applications, such as the detection of low-abundance biomarkers, single-particle tracking, and point-of-care diagnostics with low-cost portable devices, will benefit from even higher brightness. With their size-dependent optical properties, amplifying the brightness of QDs is not a simple matter of increasing the nanocrystal size. Instead, multiple copies of QDs must be assembled into a larger nanoparticle (NP) entity. In this chapter, we describe methods for the preparation and characterization of supra-nanoparticle assemblies of QDs (supra-QDs). The supra-QDs feature many individual QDs bound to a silica NP scaffold and are functionalized with dextran to improve colloidal stability. Both pure colors and composite colors of supra-QD are possible. We also describe two methods for the selective immunofluorescent labeling of an extracellular biomarker with supra-QDs: the use of tetrameric antibody complexes (TAC) and covalently linked supra-QD-antibody conjugates.
Indexed as
Identifiers
42563055What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.